J. G. Weers and J. Bell, Pulmonary Formulations: What Remains to be Done?, J Aerosol Med Pulm Drug Deliv, vol.23, 2010.

K. Amighi, La délivrance pulmonaire : une nouvelle voie d'accès pour les médicaments-état de l'art, réalisations et perspectives. Académie royale de Médecine de Belgique, 2014.

M. T. Newhouse, Drug Delivery: Pulmonary Delivery. Encyclopedia of Pharmaceutical Technology, pp.1279-1286, 2007.

M. B. Chougule and B. K. Padhi, Development of Dry Powder Inhalers. Recent Pat Drug DelivFormul, vol.1, pp.11-21, 2007.

W. H. Dehaan and W. H. Finlay, Predicting Extrathoracic Deposition from Dry Powder Inhalers, Aerosol sci, vol.35, pp.309-331, 2004.

A. Schoubben and P. Blasi, Capsule and Device: An Imperative Menage a Trois for Respirable Dry Powders, Int J Pharm, vol.494, pp.40-48, 2015.

S. R. Babubehara, I. Larson, P. Kippax, D. Morton, and P. Stewart, The Kinetic of Cohesive Powder De-agglomeration from Three Inhaler Devices, Int J Pharm, vol.421, pp.72-81, 2011.

Z. B. Tong, B. Zheng, R. Y. Yang, A. B. Yu, and H. K. Chan, CFD-DEM investigation of the Dispersion Mechanisms in Commercial Dry Powder Inhalers, Powder Technol, vol.240, pp.19-24, 2013.

J. Yang, C. Wu, and M. Adams, Three-dimensional DEM-CFD analysis of air-flow induced detachment of API particles from carrier particles in dry powder inhalers, Acta Pharm Sin B, 2014.

S. T. Jayaraju, M. Brouns, S. Verbanck, and C. Lacor, Fluid flow and particle deposition analysis in a realistic extrathoracic airway model using unstructured grids, Aerosol Sci, vol.38, pp.494-508, 2007.

P. F. Ghalati and E. Keshavarzian, Numerical analysis of micro-and nano-particle deposition in a realistic human upperairway, ComputBiol Med, vol.42, pp.39-49, 2012.

W. H. Dehaan and W. H. Finlay, Predicting Extrathoracic Deposition from Dry Powder Inhalers, Aerosol sci, vol.35, pp.309-331, 2004.

G. Surcin, Simulations lagrangiennes d'écoulements de poudre pour inhalation dans la tuyère de l'impacteur en cascade Andersen *Thèse+. *Faculté de Pharmacie+: Université Henry Poincaré-Nancy 1, 2007.

B. Romuald, Etude des paramètres influençant le transport des aérosols solides médicamenteux dans les voies respiratoires supérieures : application à la tuyère d'admission de la Pharmacopée, 2014.

N. R. Labiris and M. B. Dolovich, Pulmonary Drug Delivery. Part I: Physiological Factors affecting Therapeutic Effectiveness of Aerosolized Medications, Br J ClinParmacol, vol.56, pp.588-599, 2003.

N. Wauthoz and P. Deleuze, Temozolomide-Based Dry Powder Formulations of Lung TumorRelated Inhalation Treatment, Pharm Res, vol.28, pp.762-775, 2011.

J. Varshosaz and . Hassanzadeh, Feasability of Haloperidol-Anchroed Albumin Nanoparticles Loaded with Doxorubicin as Dry Powder Inhaler for Pulmonary Delivery, Pharm Dev Technol, vol.20, pp.183-196, 2015.

S. Faure, M. Guerriaud, and N. Clère, La phase d'absorption des médicaments. Bases fondamentales en pharmacologie, 2014.

W. C. Hinds, Aerosol Technology : Properties, Behavior, and Measurement of Airborne Particles, 1999.

A. Kleitz and D. Boulaud, Granulométrie des particules en mouvement et des aérosols, 1995.

A. Bocquier, Interet des Données de Remboursement de l'Assurance-Maladie pour l'Etude des Disparités Territoriales de la Prévalence de l'Asthme. Revue d'Epidemiologie et de Santé Publique, pp.155-162, 2012.

. Améli-santé, Définition et Diagnostic de l'Asthme, 2013.

I. Zaïen, Epidémiologie de l'Asthme chez la Femme au Cours de la Vie, Rev Mal Respir, vol.7, pp.98-100, 2015.

. Inserm and . Broncho, Pneumopathie Chronique Obstructive, Consulté en ligne le 06/07/2016 à l'adresse, 2015.

. Amélio-santé, La Broncho Pneumopathie Chronique Obstructive, 2016.

A. Boubaya and V. Vanneph, Médicaments Administrés par Voie Nasale, Bronchodilatateurs de Très Longue Durée d'Action et Aerosolthérapie, 2014.

. Vidal, , 2016.

M. Expo, Nébuliseur à tamis vibrant Geratherm®, 2016.

M. Médical, Aérosol Nébuliseur Ultrasonique Omron U17®, 2016.

S. P. Newman and W. W. Busse, Evolution of Dry Powder Inhaler Design, Formulation and Performance, Respir Med, vol.96, pp.293-304, 2002.

F. Soulié, Cohésion par Capillarité et Comportement Mécanique en Milieu Granulaires, 2005.

Z. Xu, H. M. Mansour, and T. Mulder, Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 2. IpratropiumBromide Monohydrate and FluticasonePropionate, J PharmSci, vol.99, pp.3415-3429, 2010.

M. J. Telko and A. J. Hickey, Dry Powder Inhaler Formulation, Respir Care, vol.50, issue.9, pp.1209-1236, 2005.

S. C. Das, S. R. Babubehara, D. Morton, I. Larson, and P. J. Stewart, Importance of Particle Size and Shape on the Tensile Strength Distribution and De-agglomeration of Cohesive Powders, Powder Technol, vol.249, pp.297-203, 2013.

S. R. Babubehara, I. Larson, P. Kippax, D. Morton, and P. Stewart, The Kinetic of Cohesive Powder De-agglomeration from Three Inhaler Devices, Int J Pharm, vol.421, pp.72-81, 2011.

J. Yang, C. Wu, and M. Adams, Three-dimensional DEM-CFD analysis of air-flow induced detachment of API particles from carrier particles in dry powder inhalers, Acta Pharm Sin B, 2014.

H. M. Mansour, Z. Xu, and A. J. Hickey, Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 1. Albuterol Sulfate and Disodium Cromoglycate, J Pharm Sci, vol.99, pp.3415-3429, 2010.

H. M. Mansour, Z. Xu, and A. J. Hickey, Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 2. Ipatropium Bromide Monohydrate and Fluticasone Propionate, J Pharm Sci, vol.99, pp.3415-3429, 2010.

H. M. Mansour, Z. Xu, and A. J. Hickey, Dry powder aerosols generated by standardized entrainment tubes from alternative sugar blends: 3.Trehalose dihydrate and D-mannitol carriers, J Pharm Sci, vol.99, pp.3430-3441, 2010.

M. D. Jones and R. Price, The Influence of Fine Excipient Particles on the Performance of CarrierBased Dry Powder Inhalation Formulations, Pharm Res, vol.23, issue.8, 2006.

F. Grasmeijer, A. J. Lexmond, and M. Van-den-noort, New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation, PLoS ONE, vol.9, issue.1, 2014.

G. Pilcer, N. Wauthoz, and K. Amighi, Lactose Characteristics and the Generation of the Aerosol, Adv Drug Deliv Rev, vol.64, pp.233-56, 2012.

X. M. Zeng, G. P. Martin, and S. Tee, Effects of Particles Size and Adding Sequence of Fine Lactose on the Deposition of Salbutamol Sulphate from Dry Powder Formulation, Int J Pharm, vol.182, pp.133-177, 1999.

M. B. Chougule, B. K. Padhi, and K. A. Jinturkar, Development of Dry Powder Inhalers. Recent Pat Drug DelivFormul, vol.1, pp.11-21, 2007.

H. Chan and N. Y. Chew, Dry Powder Aerosols: Emerging Technologies. Encyclopedia of Pharmaceutical Technology. thirdedition. James Swarbrick, pp.1428-1463, 2007.

R. E. Sievers, Formation of aqueous small droplet aerosols assisted by supercritical carbon dioxide, AerosolSciTechnol, vol.30, issue.1, pp.3-15, 1999.

, Préparation pour inhalation, p.18

K. Nahar, N. Gupta, and R. Gauvin, In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals, Eur J PharmSci, vol.49, pp.805-823, 2013.

G. R. Pitcairn, T. Lankinen, and O. P. Seppala, Pulmonary Drug Delivery from the Taifun Dry Powder Inhaler is Relatively Independant of the Patient's Inspiratory Effort, J Aerosol Med, vol.10, pp.97-104, 2000.

A. , Introduction to CFD Methodology. Fluent User's Guide, 2010.

E. Saatdjian, Phénomènes de Transport et leurs Résolutions Numériques. Editions Polytechnica, p.356, 1993.

B. Ray, R. Bhaskaran, and L. R. Collins, Introduction to CFD Basics. Cornell Online Course, 2012.

A. , Fluent Theory Guide. Fluent User's Guide, 2013.

B. Grgic, W. H. Finlay, and A. F. Heenan, Regional Aerosol Deposition and Flow Measurements in an Idealized Mouth and Throat, Aerosol Sci, vol.35, pp.21-32, 2004.

S. T. Jayaraju, M. Brouns, and S. Verbanck, Fluid Flow and Particle Deposition Analysis in a Realistic Extrathoracic Airway Model using Unstructured Grids, Aerosol Sci, vol.38, pp.494-508, 2007.

Y. S. Cheng, Aerosol Deposition in the Extrathoracic Region, Aerosol Sci Technol, vol.37, pp.659-71, 2003.

W. Wong, D. F. Fletcher, and D. Traini, The Use of Computational Approaches in Inhaler Development, Adv Drug Deliv Rev, vol.64, pp.312-334, 2012.

V. Deschodt, Mécanique des Fluides. Site web

E. A. Brun, A. Martinot-lagarde, and J. Mathieu, Mécanique des fluides, 1968.

A. Haider and O. Levenspiel, Drag Coefficient and Terminal Velocity of Spherical and Nonspherical Particles, Powder Technol, vol.58, pp.63-70, 1989.

S. Babubehara, I. Larson, and P. Kippax, Insight into Pressure Drop Dependant Efficiencies of Dry Powder Inhalers, vol.46, pp.142-148, 2012.

M. Copley, Assessing dry powder inhalers, 2010.

M. P. Timsina, G. P. Martin, and C. Marriott, Drug Delivery to the Respiratory Tract using Dry Powder Inhalers, Int J Parm, vol.101, pp.1-13, 1994.

H. Steckel and B. W. Muller, In Vitro Evaluation of Dry Powder Inhalers I: Drug Deposition of Commonly used Devices, Int J Pharm, vol.154, pp.19-29, 1997.

M. Taki, S. Ahmed, and C. Mariott, The 'Stage by Stage' Deposition of Drugs from Commercial Single-Active and Combination Dry Powder Inhaler Formulations, vol.43, pp.225-235, 2011.

N. Islam and M. J. Cleary, Developing an Efficient and Reliable Dry Powder Inhaler for Pulmonary Drug Delivery-A Review for Multidisciplinary Researchers, Medical Engineerigng and Physics, vol.34, pp.409-427, 2012.

M. Flament, P. Leterme, and A. Gayot, The Influence of Carrier Roughness on Adhesion, Content Uniformity and the In Vitro Depostion of TerbutalineSulphate from Dry Powder Inhalers, Int J Pharm, vol.275, pp.201-209, 2004.

M. Taki, C. Mariottt, and X. Zeng, Aerodynamic Depostion of Combination Dry Powder Formulation in Vitro: A Comparison of Three Impactors, Int J Pharm, vol.388, pp.40-51, 2010.

B. M. Zainudin, M. Biddiscombe, S. E. Tolfree, and M. Short, Comparaison of Bronchodilatator Responses and Deposition Patters of Salbutamol Inhaled from a Pressurised Metered Dose Inhaler, as a Dry Powder, and as a Nebulised Solution, Thorax, vol.45, pp.469-473, 1990.

M. P. Timsina, G. P. Martin, C. Marriott, D. Ganderton, and M. Yianneskis, Drug Delivery to the Respiratory Tract using Dry Powder Inhalers, Int J Parm, vol.101, pp.1-13, 1994.

P. H. Hirst, R. E. Bacon, and G. R. Pitcairn, A Compaison of the Lung Deposition of Budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients, Respiratory medicine, vol.95, pp.720-727, 2001.

M. Y. Yang, J. Gar-yan-chan, and H. Chan, Pulmonary Drug Delivery by Powder Aerosols, Journal of Controlled Release, vol.194, pp.228-240, 2014.

L. Borgstrom, T. Bengtsson, E. Derom, and R. Pauwels, Variability in Lung Deposition of Inhaled Drug, within and between Asthmatic Patients, with a pMDI and a Dry Powder Inhaler, Turbuhaler, Int J Pharm, vol.193, pp.227-230, 2000.

J. Xi and P. Longest, Effects of Oral Airway Geometry Characteristics on the Diffusional Deposition of Inhaled Nanoparticles, J Biomech Eng, vol.130, issue.1, 2008.

B. Annexe, Contours et vecteurs obtenus

, Contours de vitesse (en m/s) de la phase continue pour un débit de 60 L/min Vecteurs vitesse (en m/s) de la phase continue pour un débit de 60 L/min